Literature DB >> 10672498

Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.

S T Ju1, K Matsui, M Ozdemirli.   

Abstract

Fas (CD95) and Fas ligand (FasL) are a receptor/ligand pair critically involved in lymphocyte homeostasis and peripheral tolerance such that genetic defect in either Fas or FasL results in an autoimmune lymphoproliferative syndrome. Fas is a type I transmembrane protein and a member of the tumor necrosis factor receptor (TNFR) family whereas FasL is a type II transmembrane protein and a member of TNF family. Binding of Fas by FasL induces apoptosis of the Fas-expressing cells. In the past few years, Fas/FasL interaction has been connected to a series of important phenomena previously viewed as independent immune processes. The activation-induced T cell death (AICD) and the FasL-mediated cytotoxicity by activated T cells are two critical mechanisms that can account for most of these phenomena. It is in the context of the two mechanisms that we discuss in this review the molecular and cellular events that occur during T/T and T/B interactions that account for the down-regulation of the immune response. We have also discussed recent advances in the areas of FasL gene regulation, lymphokine regulation of AICD, and regulation of B cell susceptibility to FasL. Investigation in these areas should help elucidate the role of Fas/FasL in the complex network of regulatory mechanisms that control immune response and autoimmunity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10672498     DOI: 10.3109/08830189909088495

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  12 in total

Review 1.  Viruses and apoptosis.

Authors:  B J Thomson
Journal:  Int J Exp Pathol       Date:  2001-04       Impact factor: 1.925

2.  Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice.

Authors:  Marton Keszei; Yvette E Latchman; Vijay K Vanguri; Daniel R Brown; Cynthia Detre; Massimo Morra; Carolina V Arancibia-Carcamo; Carolina V Arancibia; Elahna Paul; Silvia Calpe; Wilson Castro; Ninghai Wang; Cox Terhorst; Arlene H Sharpe
Journal:  Int Immunol       Date:  2011-01-28       Impact factor: 4.823

3.  Involvement of regulatory T cells in the immunosuppression characteristic of patients with paracoccidioidomycosis.

Authors:  Maria Carolina Ferreira; Rômulo Tadeu Dias de Oliveira; Rosiane Maria da Silva; Maria Heloisa Souza Lima Blotta; Ronei Luciano Mamoni
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

4.  Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) mediates p38 mitogen-activated protein kinase activation and signal transduction in peripheral blood mononuclear cells from patients with lupus nephritis.

Authors:  Liu Zhi-Chun; Zhou Qiao-Ling; Liu Zhi-Qin; Li Xiao-Zhao; Zuo Xiao-xia; Tang Rong
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

5.  A FAS-ligand variant associated with autoimmune lymphoproliferative syndrome in cats.

Authors:  Danielle Aberdein; John S Munday; Barbara Gandolfi; Keren E Dittmer; Richard Malik; Dorian J Garrick; Leslie A Lyons
Journal:  Mamm Genome       Date:  2016-10-21       Impact factor: 2.957

6.  Noninvasive imaging of cell death using an Hsp90 ligand.

Authors:  Danielle Park; Anthony S Don; Tania Massamiri; Amol Karwa; Beth Warner; Jan MacDonald; Christine Hemenway; Arati Naik; Kah-Tiong Kuan; Pierre J Dilda; Jason W H Wong; Kevin Camphausen; Lori Chinen; Mary Dyszlewski; Philip J Hogg
Journal:  J Am Chem Soc       Date:  2011-02-15       Impact factor: 15.419

7.  Bcl10 can promote survival of antigen-stimulated B lymphocytes.

Authors:  Maoxin Tim Tian; Gabriel Gonzalez; Barbara Scheer; Anthony L DeFranco
Journal:  Blood       Date:  2005-05-05       Impact factor: 22.113

8.  Sensitizing antigen-specific CD8+ T cells for accelerated suicide causes immune incompetence.

Authors:  Christoph Wasem; Diana Arnold; Leslie Saurer; Nadia Corazza; Sabine Jakob; Simon Herren; Claudio Vallan; Christoph Mueller; Thomas Brunner
Journal:  J Clin Invest       Date:  2003-04       Impact factor: 14.808

Review 9.  The molecular study of IFNβ pleiotropic roles in MS treatment.

Authors:  Maryam Kay; Zohreh Hojati; Fariba Dehghanian
Journal:  Iran J Neurol       Date:  2013

10.  PMA and ionomycin induce glioblastoma cell death: activation-induced cell-death-like phenomena occur in glioma cells.

Authors:  Sheng Han; Xinxin Tie; Lingxuan Meng; Yunjie Wang; Anhua Wu
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.